NASDAQ:RAIN Rain Oncology (RAIN) Stock Price, News & Analysis → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free RAIN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.21▼$1.2150-Day Range$1.20▼$1.2452-Week Range$0.82▼$11.32VolumeN/AAverage Volume550,818 shsMarket Capitalization$44.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Rain Oncology alerts: Email Address Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... About Rain Oncology Stock (NASDAQ:RAIN)As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.Read More Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... RAIN Stock News HeadlinesMay 2, 2024 | msn.comWeather Impact Day: Heavy rain, possible thunderstorms on SaturdayMay 2, 2024 | msn.comJohnson & Johnson wants to pay $6.5B to settle talcum-powder lawsuits over cancer claimsMay 3, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...May 2, 2024 | yahoo.comWatch David Gilmour wring every ounce of emotion from the guitar solo on Prince's Purple Rain – with Tom JonesMay 1, 2024 | msn.comTalking to your kids about child abuseMay 1, 2024 | msn.comBeloved WSU dog dies after valiant battle with cancerMay 1, 2024 | msn.comBBC Strictly Come Dancing's Amy Dowden says 'I never wanted' and issues career announcement after cancer fightMay 1, 2024 | uk.news.yahoo.com‘I want to walk the equivalent of a marathon every week’ – Allyson, 60, sets herself a charity challenge after twice being treated for cancerMay 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.April 30, 2024 | msn.comBBC Strictly Come Dancing's Amy Dowden 'can't believe it' as she shares major news after cancer treatmentApril 30, 2024 | msn.comAmy Dowden announces book offering ‘solace and inspiration’ after cancer battleApril 29, 2024 | msn.comWinner of US$1.3 billion Powerball jackpot is an immigrant from Laos who has cancerApril 29, 2024 | msn.comAlarm Frontman Mike Peters Reveals New Cancer Diagnosis, Band Postpones 2024 North American TourApril 29, 2024 | msn.com$1.3B Powerball winner is Laos-born immigrant battling cancerApril 29, 2024 | msn.comRain is in Friday's forecast. What to expect for Kentucky Oaks 2024 at Churchill DownsApril 29, 2024 | msn.comExact date Britain will be hotter than Menorca as 24C heatwave hits in daysApril 28, 2024 | msn.comPancreatic cancer fundraising event canceled amid protests on Auraria CampusApril 27, 2024 | uk.news.yahoo.comSad farewell to legendary window cleaner 'devoted to his job rain or shine' for 50 yearsApril 26, 2024 | msn.comWhat Are MLB Rain Delay Rules In 2024? All You Need To KnowApril 26, 2024 | uk.news.yahoo.comAt least 70 people killed by flooding in Kenya as more rain is expected through the weekendApril 25, 2024 | msn.comLocal cancer survivor gives back by doing one of his favorite hobbiesApril 25, 2024 | yahoo.comBuresh Blog: Drying trend... Florida weather summit... PurpleStride for pancreatic cancerApril 25, 2024 | msn.com‘Rain makes grain’: Farmers prep for upcoming moistureApril 24, 2024 | msn.comAfter rain this weekend, we could get a taste of summerApril 23, 2024 | msn.comArkansas Storm Team Forecast: Rain chances return into mid-week; then storms for late-weekApril 22, 2024 | mirror.co.ukBritain's Got Talent winners now - soap fame, cancer recovery and a tragic deathApril 19, 2024 | msn.comSouth Carolina doctors recommend screenings for head and neck cancerSee More Headlines Receive RAIN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rain Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today5/03/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:RAIN CUSIPN/A CIK1724979 Webwww.rainthera.com Phone510-953-5559FaxN/AEmployees63Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-75,720,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-82.96% Return on Assets-68.31% Debt Debt-to-Equity RatioN/A Current Ratio5.58 Quick Ratio5.58 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.11 per share Price / Book0.39Miscellaneous Outstanding Shares36,380,000Free Float30,047,000Market Cap$44.02 million OptionableOptionable Beta0.27 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Avanish Vellanki M.B.A. (Age 49)Co-Founder, CEO & Chairman Comp: $959.75kDr. Robert C. Doebele M.D. (Age 53)Ph.D., Co-Founder, Chairman of Scientific Advisory Board, President & CSO and Chief Medical Officer Comp: $700.56kMs. Josephine Bruce (Age 45)Principal Financial & Accounting officer Ms. Theresa O'Connell M.S.Director of Corporate Development & OperationsMr. Erik Atkisson (Age 52)General Counsel & Chief Compliance Officer Ms. Charmi TurnerVice President of People & CultureMs. Vijaya Tirunagaru Ph.D.Senior VP & Head of ResearchDr. Nora Ku M.D.MD & VP of Clinical DevelopmentMore ExecutivesKey CompetitorsLianBioNASDAQ:LIANBiora TherapeuticsNASDAQ:BIOREvaxion Biotech A/SNASDAQ:EVAXPMV PharmaceuticalsNASDAQ:PMVPFibroGenNASDAQ:FGENView All CompetitorsInsiders & InstitutionsPenderFund Capital Management Ltd.Bought 38,650 shares on 2/14/2024Ownership: 0.106%Russell Investments Group Ltd.Sold 370,925 shares on 2/5/2024Ownership: 0.069%Kevin C TangSold 40,132 sharesTotal: $48,559.72 ($1.21/share)Kevin C TangSold 109,435 sharesTotal: $131,322.00 ($1.20/share)Kevin C TangBought 131,631 shares on 10/13/2023Total: $130,314.69 ($0.99/share)View All Insider TransactionsView All Institutional Transactions RAIN Stock Analysis - Frequently Asked Questions Should I buy or sell Rain Oncology stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rain Oncology in the last year. There are currently 10 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RAIN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAIN, but not buy additional shares or sell existing shares. View RAIN analyst ratings or view top-rated stocks. How were Rain Oncology's earnings last quarter? Rain Oncology Inc. (NASDAQ:RAIN) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.64) by $0.06. When did Rain Oncology IPO? Rain Oncology (RAIN) raised $126 million in an IPO on Friday, April 23rd 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO. This page (NASDAQ:RAIN) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsUrgent Nvidia WarningAltimetryCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Gates is all about this tiny $2 stockTimothy Sykes$5,000 Gold?Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.